Upload
roberto-sacoto
View
213
Download
1
Embed Size (px)
Citation preview
0
Msc. Mechanical Engineering
CME8056
Manufacturing, Materials and Processes
“The design history of the artificial heart”
By Roberto Sacoto M.
Student number: 120395769
28/04/2014
1
The design history of the artificial heart
Introduction
The heart is one of the most important organs in the human body, even to have pulse, is
considered as sign of life. A great quantity of people around the world suffers of heart failure,
and in numerous cases when the heart condition is severe, is strictly mandatory to make a
heart transplant. Moreover, in the world exists a high demand of heart donors, but there is no
possibility to cover it. For this reason, the necessity to create an alternative to replace the ill
heart marked the origin of the artificial heart.
Along the history, the development of the artificial heart have passed through many
contemplations, since the early models across to the current day versions, where new
technology and design has been applied trying to achieve always better results. As Sheppard
comments, several years have passed since the first successful heart-‐lung machine was applied
on a human in 1953. However, four years after the first “artificial heart” (made from plastic)
was implanted inside a dog. Subsequently, since the decade of 1960s some devices were
developed with limited achievements.
In the year of 1982 the first successful artificial heart transplant was performed, where the
patient survived 112 days. This fact brought plenty interest for the developing of the total
artificial heart (TAH). This included new studies of the technology used in this mechanical
device, in order to improve the compatibility between both the human body and the artificial
heart to avoid the rejection of it, or any other possible problems, such as infections provoked
after the implantation of the artificial device. According to a report from the Natural Heart
Institute, the ideal materials to be used need to have some the next characteristics: should not
modify blood or tissue electrolyte composition, not cause allergic or toxic reactions and must
not interfere with the body’s normal defence mechanisms to prevent cancer generation and
harm the blood and tissues. Although the heart is conceptually a simple organ (a muscle that
works as pump), it involves complex finesses that challenge the direct simulation using power
supplies and synthetic materials.
In these days the artificial heart has been used for temporary support until a natural heart can
be transplanted, which is a considerable limitation because the native heart is removed.
Nevertheless, this inconvenient encouraged the development of the ventricular assist devices.
In this work some of the most relevant artificial heart devices are going to be discuss, with the
intention to highlight their achievements and limitations. Moreover, is important to say that
every one of them has been important in the field of medicine research.
2
The artificial hear through the time
Early models
The Liotta Total Artificial Heart
This device is considered the first artificial
heart implanted in a human. Developed in
the decade of 1960s by Dr. Domingo Liotta,
it was implanted in a 47-‐year-‐old patient.
Work description and materials technology
This apparatus was a pneumatic pump with
double-‐ventricle input and output. Four
valves controlled the flow of blood across
the intake and outtake areas of the pump.
Basically, it was handmade with materials
like polyester (Dracon) and silicon (Silastic) tubing. The figure 1 shows the needlework used to
join the tubing with chamber fabric. An external unit controlled the two pneumatic units that
generated the vacuum and pumping actions to move the blood across the mechanical heart.
Akutsu III Total Artificial Heart
In the year of 1982, a new prosthesis
designed by Dr. Tetsuzo Akutzu was
implanted on a 36-‐year-‐old man.
Work description and materials technology
This device contained two double-‐
chambered pumps powered by air. The
prosthetic ventricles were attached to the
remnants of the natural heart’s atria and
the vessels by flexible detachable quick-‐
connectors. The control console had a large size and a more complex control system. The
figure 2 shows the orthotopic placement of the device.
Design Achievements:
-‐ Complete artificial heart
-‐ Continuous-‐flow pump in humans
-‐ A new soft material was used in the pumping chambers, called Avcothane, which has
the property to resist to the bacteria development.
Figure 1. Liotta total artificial heart http://www.theatlantic.com/technology/archive/2010/10/the-‐worlds-‐first-‐artificial-‐heart/63949/
Figure 2. Diagram showing the orthotopic placement of the Akutsu III TAH
Total artifical heart in two stages transplantation
3
Limitations
-‐ Skin-‐piercing tubes (infections may occur)
-‐ Not portable and very complex system
-‐ Complex control system and short term support
Jarvik 7 Total Artificial heart
Designed to work as a natural heart by Dr. Robert Jarvik, the
Jarvik 7 (fig. 3) was successfully implanted in 1982. The
patient survived 112 days with this artificial device (Franklin
Inst.).
Work description and materials technology
As an improving in the design this device had two pumps
much similar to the hearts ventricles. The polyurethane
ventricles where sphere-‐shaped, and had a disk-‐shaped
mechanism to push the blood from the inlet valve to the
outlet valve. As its predecessors, polyester was still used in
cuffs to attach the device to the natural heart’s atria. Also
aluminium was used on the valves internal parts. The artificial heart’s pneumatic out drivelines
were made of polyurethane tubing. At the skin exit the drivelines were covered with velour-‐
covered Silastic material to encourage tissue generation.
The mechanical heart was pneumatic powered by an external control system. The control
console was large and heavy. However, it has a more detailed control panel that allowed the
doctors to manage the control pump rate, pumping pressure and other functions.
Design Achievements:
-‐ More efficient design (truly successful artificial heart, longer support time)
-‐ Better manufacturing quality and control safety improvement
-‐ Patient is transportable (the external control system included air scuba and battery
power back up during transportation)
Limitations:
-‐ Large external console
-‐ Was not permanent
-‐ Skin-‐piercing tubes and health risks (compatibility rejection and organ failure had
presented in some cases)
Figure 3. Jarvik 7 total artificial heart
http://www.smithsonianlegacies.si.edu/objectdescription.cfm?ID=172
4
Actual models
SynCardia Total Artificial Heart
The Syncardia total artificial heart is a design based on
the previous Jarvik 7 model (Texas Heart Institute).
However it has been developed with new more
reliable materials.
Work description and materials technology
It is basically a pneumatic pump, externally air
powered. The base assembly is fabricated form
IsoPlast, engineered polyurethane. The doom-‐like
thermoplastic chamber housing is fabricated from
segmented polyurethane solution (SPUS), overlaid on
a Dracon Mesh. Multiple layers of SPUS are utilized to
fabricate the blood chamber, all applied via sequential
pouring over a mould. As can be appreciated in figure 4, this device has the option of a
portable external device, which allows the patient to be transported and perform some daily
activities.
Design Achievements:
-‐ Smaller and More efficient design (longer support time, used as a bridge between
transplant, approximate time of 18 months)
-‐ Use of reliable materials and better manufacturing control
-‐ Portable control device available to transport the patient
-‐ Heart system repair and calibration can be made externally
Limitations:
-‐ Skin-‐piercing tubes (infections may occur)
-‐ Temporary Treatment (bridge), very expensive
AbioCor Total Artificial Heart
The AbioCor TAH is the first completely self-‐contained total artificial heart.
Work description and materials technology
Dissimilar to the artificial hearts of the past, patients are not tied to a large, air-‐pumping
console nor do they have wires or tubes piercing their skin. The internal device it’s a motor-‐
driven hydraulic pump. The pressure is created by the motors rotation between 4000 to 8000
rpm. The figure 5 indicates the internal system of the AbioCor TAH, which apart has an
Figure 4. Syncardia total artificial heart connected to a portable control device http://transplants.ucla.edu/body.cfm?id
=223
5
emergency rechargeable battery that is continuously charged by an external power source. A
big difference from the other TAH is that this device has
a wireless energy transfer system that is based on a
transcutaneous energy transmission. The Texas Heart
Institute describes that it consists of internal and
external coils that are used to transmit power across
the skin. Because tubes or wires do not pierce the skin,
the chances of developing an infection are decreased.
External battery packs can power the AbioCor for 4
hours.
Achievements:
-‐ Internal powered device with internal control
drive system
-‐ Completely self-‐portable (compact, safe, life
time of 2 years approx.)
-‐ AngioFlex and Titanium conform the principal
materials of the device.
-‐ Less risk o infection due to no skin-‐piercing wires and tubing.
Limitations:
-‐ Heavy (2 pounds approx.) and large size device – only fits 50% of U.S. males (Luber)
-‐ Limited battery life (4 hours)
-‐ Complicated anticoagulation management
-‐ Very expensive (around 250000 dollars, Washington Post)
Novel devises
Carmat Hydraulic Artificial Heart
It consists of two cavities, imitating the organ’s
ventricles, which are separated by a moving membrane
that’s hydraulically powered via a special drive fluid. This
membrane reproduces the action of the ventricular wall
during contractions, creating blood flow in and out of
the device. The system works in conjunction with
sensors and a microcontroller that continuously adjust
the activity of the prosthesis to match the needs of the
Figure 5. AbioCor total artificial heart system
http://texasheart.org/Research/Devices/abiocor.cfm
Figure 6. Carmat Hydraulic Artificial Heart http://www.medgadget.com/2013/05/carmat-‐hydraulic-‐artificial-‐heart-‐set-‐to-‐
begin-‐human-‐trials-‐wvideo.html
6
patient. (Fig.6). The whole device is covered by compatible polymer membrane that emulates
a heart tissue. Also, all controls and sensors are internally installed.
No pulse artificial heart
This novel device (fig. 7) has been developed in
the Texas Heart Institute during the last 10
years. It was successfully implanted in the year
of 2011 in a man.
What makes it great is that this device does not
simulate the heart beating. This characteristic
defies all the actual knowledge of the human
body system, which strongly believes that
heartbeat is an important key to define the life
in the human body.
This device works as continuous turbine pump
capable to rotate at more than 10000 rpm,
leaving the patient with absolutely no pulse. It
still under development and is one of the most promising devises in the future of the cardiac
prosthesis.
Ventricular assist devices
Depending on the patients case, not always is
necessary to make a total heart transplant,
for some cases a ventricular assist device can
be use. It is a mechanical pump that is used to
support heart function and blood flow in
patients who have debilitated hearts.
Practically the design, materials and control
technology are similar to the previous
devices. However, these kinds of devices are
less invasive, which means that the heart is
not totally extracted and in some cases it can
recover its health. Figure 8 shows a
ventricular assist device installed in a patient
to help the ill heart.
Figure 7. No pulse artificial heart device http://www.kollected.com/Artificial-‐Heart
Figure 8. Ventricular assist device (Thoratec HeartMate II LVAS)
http://texasheart.org/Research/Devices/thorate
c_heartmateii.cfm
7
Conclusions
In conclusion, the last 50 years have marked a new era in the artificial organs development.
Each created device has contributed for the medical advance. Due to the necessity to fusion
the artificial device with the human body, the experimentation with new materials and power
sources increased. Although the essence of the artificial heart have not changed considerably,
new materials and technology has been applied. Since basic polymers as plastic, through more
complex polyurethane shapes, the improvement of materials is now significant advanced.
However, in the case of power sources it is still difficult and controversial. Actually, all the
artificial heart devices needs from an electrical or pneumatic power source to work, which has
been a difficulty for the system, due to the risks of infections and other problems that can
cause to the patients. However, the transportability of the person is now a reality. Backpacks
filled with lithium batteries supports the power to the mechanism system, contrasting with the
early days of the artificial heart when the patient was not able to leave the bed of the hospital.
Perhaps, in the future these mechanical devises will be able to be powered by the own human
organism, as the intention to work as one. Another remarkable event is the development of
the no pulse devise. As written before, it simply defies the previous knowledge of the human
heart, diminishing the heartbeat as one of the essential characteristics, which may influence
the future design of the total artificial heart.
Finally, the artificial heart implant shall continue to catch the public’s imagination, possibly
because the idea of it seems captivating out of this world. Hopefully, future investigations will
achieve this big goal, however it may take some several years until all the technology needed
will be available, or better say developed by the scientists.
8
References
-‐ Abiomed (19/04/2014) AbioCor [WWW Document]. URL
http://www.abiomed.com/products/heart-‐replacement/
-‐ AlNuaimi A, Mohamend N., et all. (22/04 /2014) Artificial Heart [WWW Document]. URL
http://forum.panet.co.il/showthread.php?t=49818
-‐ Baum D. (21/04/2014) No Pulse: How Doctors Reinvented The Human Heart [WWW
Document]. URL http://www.popsci.com/science/article/2012-‐02/no-‐pulse-‐how-‐doctors-‐
reinvented-‐human-‐heart
-‐ Brown D. (24/04/2014) Artificial Heart Gets Limited FDA Approval [WWW Document]. URL
http://www.washingtonpost.com/wp-‐
dyn/content/article/2006/09/05/AR2006090501309.html
-‐ Cooley D. , Akutzu T, et all. (1981)Total artifical heart in two stages transplantation.
Cardiovasc Dis. Sep 1981; 8(3): 305–319.
-‐ Kollected (25/04/2014) No Pulse: How Doctors Reinvented The Human Heart [WWW
Document]. URL http://www.kollected.com/Artificial-‐Heart -‐ Lubher S. (20/ 04/ 2014) The AbioCor system: Overview [WWW Document]. URL
http://www.slideshare.net/saluber/the-‐abiocor-‐system-‐overview
-‐ Madrigal A (20/ 04/ 2014) The World's First Artificial Heart [WWW Document]. URL
http://www.theatlantic.com/technology/archive/2010/10/the-‐worlds-‐first-‐artificial-‐
heart/63949/
-‐ Mallari K. (20/04/2014) Fake Hearts, Anyone? [WWW Document]. URL
http://agham.asti.dost.gov.ph/1998/4th/extras/astra1.htm
-‐ Medgadget (22/04/2014) CARMAT Hydraulic Artificial Heart Set to Begin Human Trials
[WWW Document]. URL http://www.medgadget.com/2013/05/carmat-‐hydraulic-‐
artificial-‐heart-‐set-‐to-‐begin-‐human-‐trials-‐wvideo.html
-‐ Sheppard L. (20/04/2014) Artificial Heart [WWW Document]. URL
http://www.madehow.com/Volume-‐6/Artificial-‐Heart.html#ixzz2zRZGH8xC -‐ Slepian M, Alemu Y., et all (2012) The SyncardiaTM total artificial heart: in vivo, in vitro, and
computational modeling studies. Pages 267-‐274
-‐ Smithsonian institution Press (20/ 04/ 2014) Jarvik-‐7 artificial heart, 1985 [WWW
Document]. URL http://www.smithsonianlegacies.si.edu/objectdescription.cfm?ID=172
-‐ SynCardia Systems Inc. (23/04/2014) Total Artificial Heart Facts [WWW Document]. URL
http://www.syncardia.com/total-‐facts/total-‐artificial-‐heart-‐facts.html
-‐ Texas Heart Institute (21/04/2014) Heart Assist Devises [WWW Document]. URL
http://texasheart.org/Research/Devices/thoratec_heartmateii.cfm
-‐ UCLA Transplantation Services (19/04/2014) SynCardia Total Artificial Heart [WWW
Document]. URL http://transplants.ucla.edu/body.cfm?id=223